cytarabine has been researched along with triazinate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colsky, J; Cummings, FJ; Gelman, R; Israel, L; Kuperminc, M; Skeel, RT; Tormey, D | 1 |
| Marsh, JC | 1 |
1 trial(s) available for cytarabine and triazinate
| Article | Year |
|---|---|
Phase II trials of Baker's antifol, bleomycin, CCNU, streptozotocin, tilorone, and 5-fluorodeoxyuridine plus arabinosyl cytosine in metastatic breast cancer.
Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Female; Floxuridine; Humans; Lomustine; Probability; Streptozocin; Tilorone; Triazines | 1981 |
1 other study(ies) available for cytarabine and triazinate
| Article | Year |
|---|---|
Comparative effects of methotrexate, two nonclassic folic acid antagonists, and cytarabine on hematopoietic precursor cells.
Topics: Animals; Cell Survival; Colony-Forming Units Assay; Cytarabine; Dogs; Dose-Response Relationship, Drug; Folic Acid Antagonists; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Methotrexate; Mice; Quinazolines; Species Specificity; Triazines; Trimetrexate | 1982 |